Superior Group of Companies, Inc. filings document financial results, governance votes, Regulation FD disclosures and capital-return activity for an operating company with Healthcare Apparel, Branded Products and Contact Centers segments. Form 8-K reports furnish quarterly results, investor presentations and related exhibits covering operating performance and financial condition.
The company’s proxy and annual-meeting filings document director elections, auditor ratification and executive-compensation disclosures. Other material-event filings address share repurchase arrangements, including a Rule 10b5-1 trading plan tied to the company’s common stock repurchase program.
DEMOTT ANDREW D JR reported acquisition or exercise transactions in this Form 4 filing.
SUPERIOR GROUP OF COMPANIES, INC. director Andrew D. DeMott Jr. received a grant of 9,583 shares of Common Stock as a restricted stock award. The award carries no purchase price and vests on the third anniversary of the grant date, or May 7, 2029.
On the grant date, the issuer’s common stock closed at $12.00 per share on NASDAQ. After this grant, DeMott directly owns 209,809 shares of Common Stock, of which 29,731 shares are restricted and remain subject to forfeiture as of this filing.
Spencer Loreen M reported acquisition or exercise transactions in this Form 4 filing.
SUPERIOR GROUP OF COMPANIES, INC. director Loreen M. Spencer received a grant of 9,583 shares of common stock as a restricted stock award on May 7, 2026. The award vests on May 7, 2029. The issuer’s stock closed at $12.00 that day, and Spencer now holds 25,694 shares in total, of which 22,194 remain subject to forfeiture.
Lattmann Susan E. reported acquisition or exercise transactions in this Form 4 filing.
SUPERIOR GROUP OF COMPANIES, INC. director Susan E. Lattmann received a grant of 9,583 shares of common stock as a restricted stock award on May 7, 2026, at no cash cost to her. The award vests on May 7, 2029.
The filing notes that the issuer’s common stock closed at $12.00 per share on NASDAQ on the grant date, giving a clear reference value for the award. After this grant, 22,194 shares held by Lattmann remain subject to forfeiture under restricted stock terms.
SIEGEL TODD E reported acquisition or exercise transactions in this Form 4 filing.
Superior Group of Companies director Todd E. Siegel received a restricted stock award of 9,583 shares of common stock on May 7, 2026. The shares were granted at no cash cost as equity compensation and will vest on the third anniversary of the grant date, or on May 7, 2029.
After this award, Siegel directly holds 75,607 shares of Superior Group common stock, including 29,731 shares that remain subject to forfeiture under restricted stock terms. On the grant date, the issuer’s stock closed at $12.00 per share on NASDAQ, indicating the market value used to reference the award.
Mellini Paul V reported acquisition or exercise transactions in this Form 4 filing.
SUPERIOR GROUP OF COMPANIES, INC. director Paul V. Mellini reported receiving a grant of 10,000 shares of common stock as a restricted stock award. The award carries no cash purchase price and will vest on the third anniversary of the grant date, or on 05/07/2029.
Following this grant, Mellini directly holds 119,912 shares of common stock, including 31,368 shares that are still subject to forfeiture under existing restricted stock awards as of the filing date.
KOEMPEL MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
Superior Group of Companies, Inc. President & CFO Michael Koempel received a grant of 60,500 shares of common stock as a restricted stock award at no cash cost on May 7, 2026. These shares vest on May 7, 2029 and are subject to forfeiture. On the grant date, the issuer’s common stock closed at $12.00 per share on NASDAQ. Following this award, Koempel directly holds 139,730 shares of common stock, of which 114,851 shares remain subject to forfeiture under restricted stock terms.
BENSTOCK MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
SUPERIOR GROUP OF COMPANIES, INC. CEO Michael Benstock received a grant of 120,000 shares of common stock as a restricted stock award on May 7, 2026, at a stated price of $0.00 per share. The award vests on the third anniversary of the grant date, or on May 7, 2029.
On the grant date, the company’s common stock closed at $12.00 per share on NASDAQ. Following this grant, Benstock directly holds 710,637 shares of common stock, some of which remain subject to forfeiture, including 193,571 shares as of this filing. Indirect holdings include 22,000 shares held by his spouse and 397,006 shares held in an irrevocable trust for which he disclaims beneficial ownership.
Alpert Jordan M. reported acquisition or exercise transactions in this Form 4 filing.
SUPERIOR GROUP OF COMPANIES, INC. Chief Legal Officer and Secretary Jordan M. Alpert received a grant of 10,000 shares of common stock as a restricted stock award on May 7, 2026. These shares vest on the third anniversary of the grant date, or May 7, 2029.
The filing notes that the company’s common stock closed at $12.00 per share on NASDAQ on the grant date. Following this award, Alpert directly holds 89,151 shares of common stock, of which 39,402 are restricted shares that remain subject to forfeiture as of the filing date.
Superior Group of Companies, Inc. held its Annual Meeting of Shareholders on May 7, 2026. Of the 15,704,912 shares outstanding and entitled to vote, 13,718,077 shares were represented in person or by proxy, indicating strong participation.
Shareholders elected all seven director nominees, including Michael Benstock, Paul Mellini, Todd Siegel, Michael Koempel, Andrew D. Demott Jr., Susan Lattmann and Loreen Spencer. Each nominee received more votes "For" than "Against."
Investors also approved the ratification of Grant Thornton LLP as the company’s independent registered public accounting firm for the year ending December 31, 2026, with 13,676,626 votes "For," 22,681 "Against" and 18,770 "Abstain," and no broker non-votes.
Superior Group of Companies reported Q1 2026 results showing a return to profitability and stronger cash generation. Net sales for the three months ended March 31, 2026 were $140.9 million, up 2.8% from $137.1 million a year earlier, driven by growth in Branded Products and Healthcare Apparel.
The company generated net income of $0.8 million versus a loss of $0.8 million in Q1 2025, with diluted EPS of $0.06. Consolidated gross margin improved to 37.1%, helped by better mix and pricing in Branded Products, while Healthcare Apparel margins softened slightly and Contact Centers margins declined.
EBITDA rose to $4.8 million from $3.5 million as higher gross profit and lower interest expense offset higher selling and administrative costs in Healthcare Apparel, including $1.0 million of severance. Operating cash flow improved to $9.4 million, aided by lower accounts receivable, and cash ended at $23.2 million. Total debt declined to $87.3 million, and the company remained in compliance with credit facility covenants while continuing dividends and share repurchases.